Your browser doesn't support javascript.
loading
Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study.
Thurman, Andrea R; Brache, Vivian; Cochon, Leila; Ouattara, Louise A; Chandra, Neelima; Jacot, Terry; Yousefieh, Nazita; Clark, Meredith R; Peet, Melissa; Hanif, Homaira; Schwartz, Jill L; Ju, Susan; Marzinke, Mark A; Erikson, David W; Parikh, Urvi; Herold, Betsy C; Fichorova, Raina N; Tolley, Elizabeth; Doncel, Gustavo F.
Afiliación
  • Thurman AR; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America.
  • Brache V; Profamilia, Santo Domingo, Dominican Republic.
  • Cochon L; Profamilia, Santo Domingo, Dominican Republic.
  • Ouattara LA; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America.
  • Chandra N; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America.
  • Jacot T; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America.
  • Yousefieh N; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America.
  • Clark MR; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America.
  • Peet M; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America.
  • Hanif H; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America.
  • Schwartz JL; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America.
  • Ju S; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America.
  • Marzinke MA; Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
  • Erikson DW; Endocrine Technologies Core (ETC), Oregon National Primate Research Center (ONPRC), Beaverton, OR, United States of America.
  • Parikh U; Department of Medicine, Division of Infectious Diseases and Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, PA, United States of America.
  • Herold BC; Albert Einstein College of Medicine, Bronx, NY, United States of America.
  • Fichorova RN; Laboratory of Genital Tract Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States of America.
  • Tolley E; Family Health International 360, Research Triangle, NC, United States of America.
  • Doncel GF; CONRAD, Eastern Virginia Medical School, Norfolk and Arlington, VA, United States of America.
PLoS One ; 17(10): e0275794, 2022.
Article en En | MEDLINE | ID: mdl-36215267
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Levonorgestrel / Anticonceptivos / Dispositivos Anticonceptivos Femeninos / Tenofovir / Anovulación Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Levonorgestrel / Anticonceptivos / Dispositivos Anticonceptivos Femeninos / Tenofovir / Anovulación Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos